Compare Toronto-Dominion Bank (TD) vs BIO-TECHNE Corp (TECH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Toronto-Dominion Bank vs BIO-TECHNE Corp — how do they compare? Toronto-Dominion Bank trades at $120.27 (market cap $197.03B), while BIO-TECHNE Corp trades at $71.63 (market cap $11.16B). The key difference: Toronto-Dominion Bank is far larger — about 17.7× BIO-TECHNE Corp's market cap, and Toronto-Dominion Bank pays the higher dividend (2.62%). Which is the better fit depends on your goals.
| TD | TECH | |
|---|---|---|
Market Cap | $197.03B | $11.16B |
Sector | Financials | Health |
52-Week High | $124.80 | $72.12 |
52-Week Low | $72.55 | $43.31 |
Dividend Yield | 2.62% | 0.45% |
Enterprise Value | — | $11.24B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Toronto-Dominion Bank
Toronto-Dominion is one of Canada's two largest banks and operates three business segments: Canadian retail banking, U.S. retail banking, and wholesale banking. The bank's U.S. operations span from Maine to Florida, with a strong presence in the Northeast. It also has a 13% ownership stake in Charles Schwab.
Read more on TD →About BIO-TECHNE Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →
